
News|Articles|July 1, 2003
Inhaled insulin superior to rosiglitazone in patients with uncontrolled type 2 diabetes
Premeal dosing of inhaled insulin may represent a valuable option for patients with type 2 diabetes.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
500,000 Medicaid beneficiaries with diabetes to lose coverage by 2034
2
Ashley Holzworth-Nash, Pharm.D., Evernorth
3
Medicaid work requirements and how states may apply them: An in-depth discussion with Eric Levine, M.P.H., of Avalere Health
4
Study shows atopic dermatitis increases shingles risk
5




















